md3434, From Twitter today, @TerraPharma1 gave us a treasure trove of golden Nuggets. The one I liked most was:
🔥UPDATE🔥 Vascepa 2.0 candidate with partner Mochida (developer of Epadel) phase 2 was apparently a success as they have just announced a Phase 3 for the once daily, self emulsifying new epa formula product (MND-2119). $AMRNhttps://t.co/JtxpE8oUXV
Wrap your head around a far better version of Vascapa within a couple of years, and before Teva's entry to take us out to 2030. How's that for getting us into triple digits?